Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes

Clinical trial NCT01554618 · COMPLETED

Trial details

NCT number: NCT01554618
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Children and Adolescent With Type 2 Diabetes

Start date: 2011-12-02
Primary completion: 2020-05-06
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.